ENGN
enGene Holdings Inc.NASDAQHealthcare$6.69-1.04%ClosedMarket Cap: $342.5M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.73
P/S
0.00
EV/EBITDA
-3.09
DCF Value
$0.28
FCF Yield
-28.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-55.8%
ROA
-36.3%
ROIC
-40.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | $0.00 | -Infinity% | $-31.2M | $-29.8M | $-0.44 | — |
| Q4 2025 | $0.00 | NaN% | $-39.5M | $-37.9M | $-0.74 | — |
| FY 2025 | $0.00 | NaN% | $-123.2M | $-117.3M | $-2.29 | — |
| Q3 2025 | $0.00 | NaN% | $-29.9M | $-29.0M | $-0.57 | — |
| Q2 2025 | $0.00 | NaN% | $-27.1M | $-25.8M | $0.51 | — |
| Q1 2025 | $0.00 | NaN% | $-26.6M | $-24.6M | $-0.48 | — |
| Q4 2024 | $0.00 | NaN% | $-17.5M | $-15.3M | $-0.34 | — |
| FY 2024 | $0.00 | NaN% | $-62.3M | $-55.1M | $-1.46 | — |
| Q3 2024 | $0.00 | NaN% | $-16.8M | $-14.1M | $-0.32 | — |
| Q2 2024 | $0.00 | NaN% | $-17.3M | $-15.0M | $-0.38 | — |
| Q1 2024 | $0.00 | NaN% | $-10.8M | $-10.7M | $-0.46 | — |
| Q4 2023 | $0.00 | NaN% | $-10.4M | $-82.5M | $-2.64 | — |